Augmented reality heightens accuracy of brain procedure
Researchers from China used augmented reality technology to visualize brain...Read more on AuntMinnie.comRelated Reading: How can virtual reality bolster image interpretation? VR, AR may revamp cardiovascular imaging Augmented reality guides orthopedic surgery SIR: Holography platform boosts reader confidence for aneurysms Augmented reality may help guide facet joint injections (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 16, 2018 Category: Radiology Source Type: news

Auris Health touts robotically-assisted bronchoscopy study results
Auris Health’s Monarch bronchoscopy platform reached lung nodules and biopsied tissue with “high accuracy” in a recent study, according to the company. Eight investigators performed robotic-assisted bronchoscopy procedures using the Monarch platform on a cadaveric model designed to mimic a real-life bronchoscopy procedure. Sixty-seven simulated tumor targets one to three centimeters in size were prepared in eight human cadaveric lungs. The tissue acquired during the bronchoscopy was evaluated and correctly identified as the implanted target in 97% of cases, the study noted. Auris presented the results of ...
Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Oncology Robotics aurishealth johnsonandjohnson Source Type: news

Abiomed claims Impella pump not at fault in patient death
Update: Includes statement from Abiomed After reporting possible issues with two of its Impella heart pumps used in an open heart surgery, Abiomed (NSDQ:ABMD) said today that the devices were not to blame for the patient’s death. The Impella devices were used in a last-attempt effort to save an elderly patient undergoing open heart surgery, Abiomed CEO Mike Minogue said in a statement sent to MassDevice.com “This was a very sick elderly patient who had poor heart function. The patient was having trouble coming off a heart and lung machine during open heart surgery. Impella was used as a last resort to...
Source: Mass Device - October 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Abiomed Source Type: news

Should Breast Surgery Be Its Own Medical Specialty? Should Breast Surgery Be Its Own Medical Specialty?
In the US, there are medical specialty boards for thoracic surgery, orthopedic surgery, head and neck surgery, colorectal surgery, and surgery for a variety of other organs/systems. But not the breast.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Day of discharge does not influence heart surgery patient readmissions
(Elsevier) Despite a common belief that weekend and holiday discharge after major heart surgery may impact hospital readmissions, research published online today in The Annals of Thoracic Surgery showed that day of discharge does not affect readmissions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 11, 2018 Category: International Medicine & Public Health Source Type: news

‘ Take Action ’ : Dave McGillivray ’s Message To Anyone Ignoring Symptoms Of Heart Disease
BOSTON (CBS) – There aren’t many people who run their age in miles every year. Dave McGillivray does. From the time he was a boy, he’s celebrated his good health and love of running with a personal challenge that obviously gets more challenging with age. His last “full” birthday run was last year: 63 miles. This year, by necessity, he split the effort into 32 miles of running and 32 miles of biking. A feat, to be sure. But this year, he is facing a challenge for which there is no training. McGillivray, arguably one of the most fit people on the planet, has coronary artery disease and is prepa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 9, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Watch Listen Dave McGillivray Lisa Hughes Mass General Hospital Source Type: news

Brooklyn Opens Its Mesothelioma Specialty Center
Mesothelioma patients from Brooklyn won’t need to travel far from home anymore to receive specialized care for this rare and aggressive cancer. The Brooklyn Mesothelioma Center has opened. Maimonides Medical Center is the top cancer facility in Brooklyn. It has been treating mesothelioma patients for many years, but the arrival of thoracic surgeon Dr. Ory Wiesel has taken its program to another level. “We can provide the care now that these patients, before, maybe went elsewhere to find,” Wiesel told Asbestos.com. “We’re creating a dedicated mesothelioma program, with the expertise necessary, ...
Source: Asbestos and Mesothelioma News - October 8, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Medrobotics touts first EU sale of Flex robotic platform
Medrobotics today touted the first sale of its Flex robotics surgical platform in Europe. The Raynham, Mass.-based company said it sold the system to Italy’s A.O. Universitaria Città della Salute e della Scienza di Torino, making the facility the first in Europe to offer procedures with the platform. Medrobotics Flex robotic surgical platform is intended for use in minimally invasive surgical procedures, and is designed specifically to access hard to reach anatomy in otolaryngology, colorectal and gastroenterology procedures, the company said. “Colorectal cancer is the second leading cause of cancer...
Source: Mass Device - October 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Robotics Surgical Medrobotics Source Type: news

BD promotes Polen to COO | Personnel Moves – October 3, 2018
Becton Dickinson (NYSE:BDX) said today it named current president Tom Polen as its new chief operating officer, filling a role that has been empty since 2016. Polen was appointed president in April 2017, and will continue to report to chairman and CEO Vincent Forlenza, the Franklin Lakes, N.J.-based company said. In his new position, Polen will have oversight of its three operating segments, its innovation and new product dev pipeline and global operations, BD said. “Tom’s promotion reflects his leadership role developing and implementing BD’s strategy and vision and aligning our businesses under thr...
Source: Mass Device - October 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News bectondickinson clicktherapeutics intersectent Intuitive Surgical johnsonandjohnson nevro shapememorymedical ViewRay Inc. Source Type: news

Preventable Cardiovascular Events Are Big Economic Burden
About 16.3 million events, totaling $ 173.7 billion in hospitalization costs, could occur in 2017 to 2021 (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 3, 2018 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Surgery, Geriatrics, Journal, Source Type: news

CAR T-Cell Therapy May ‘ Change the Paradigm of Treating Mesothelioma ’
Thoracic surgeon and scientist Dr. Prasad Adusumilli at Memorial Sloan Kettering (MSK) Cancer Center believes customized gene therapy will soon change the way pleural mesothelioma is treated. Adusumilli, director of the Mesothelioma Program at MSK, has worked for a decade on developing tumor immunology for thoracic malignancies. He is currently the principal investigator of a phase I clinical trial involving specially prepared immune cells — chimeric antigen receptor (CAR) T cells — that have shown impressive efficacy with mesothelioma. “I think this is going to change the paradigm of treating mesotheliom...
Source: Asbestos and Mesothelioma News - October 1, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

#MayoClinicRadio podcast: 9/29/18
Listen: Mayo Clinic Radio 9/29/18 On this week's Mayo Clinic Radio podcast, Dr. Shanda Blackmon, a thoracic surgeon at Mayo Clinic, explains lung cancer screening and surgical options for treating the disease. Dr. Blackmon also covers?mesothelioma, another type of cancer that often occurs in the tissue surrounding the lungs.?Also on the podcast, Dr. Jamie Van [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 1, 2018 Category: Databases & Libraries Source Type: news

Diagnosis and treatment of tuberculosis: what place is left for thoracic surgery?
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 27, 2018 Category: Respiratory Medicine Authors: GAtherton Source Type: news

New Device Offers Hope For People With Heart Failure
(CNN) — A tiny new device is offering hope of a better life for people with severe heart failure, reducing hospitalization rates and improving mortality risk within two years of treatment, a new study finds. Heart failure affects an estimated 5.7 million Americans and more than 26 million people globally, causing shortness of breath and tiredness among those affected as their heart struggles to pump blood around the body. One cause of severe heart failure that currently has a poor prognosis is a leaky valve, particularly the leakage of the mitral valve, which control’s blood flow in the left part of the heart....
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 26, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Heart Failure Local TV Source Type: news

International Symposium on Mesothelioma to Focus on Immunotherapy
The eighth annual International Symposium on Malignant Pleural Mesothelioma Saturday at UCLA will reflect the rapidly evolving philosophy on future treatment of this rare cancer. Change is coming. The Symposium, which was first held in 2011 to help bring awareness to lung-sparing surgery, will highlight groundbreaking discoveries and the latest advances in immunotherapy and gene therapy — believed to be the future of cancer care. The longtime chemotherapy and surgery standard-of-care routine is fading. The symposium at the Luskin Conference Center on the UCLA campus in Los Angeles will help explain why. “There ...
Source: Asbestos and Mesothelioma News - September 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study: Aggressive Surgery Underutilized with Pleural Mesothelioma
Aggressive surgery for the treatment of malignant pleural mesothelioma is being underutilized, costing patients significant survival time, according to a recent study. Researchers found mesothelioma patients from all three histological subtypes — epithelioid, biphasic and sarcomatoid — can benefit from surgery, despite a reluctance to perform it today. The National Comprehensive Cancer Network (NCCN), a nationwide alliance of leading cancer centers, encourages surgery only for epithelioid patients. This eliminates the option for almost 40 percent of those diagnosed with mesothelioma. “Surgery is underutil...
Source: Asbestos and Mesothelioma News - September 25, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

This Medical Clip May Be a Powerful Treatment for Heart Failure, Study Says
A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, called the MitraClip, reduced hospitalizations related to heart failure by nearly half and deaths by nearly 40% among patients with a specific and serious complication of heart failure, compared to those who received standard medical treatment. The results were published Sunday in the New England Journal of Medicine. “This therapy really offers an important new option for very desperate patients who are suffering...
Source: TIME: Health - September 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Research Source Type: news

Are You Tall? Better Watch Out For Varicose Veins
(CNN) — In what researchers are calling “the largest genetic study ever performed” on varicose vein disease, a Stanford University School of Medicine study found a person’s height to be a significant risk factor for developing varicose veins. “We not only found an association between height and varicose veins, but the genetic studies we did showed a causal link,” said cardiologist and study author Dr. Nicholas Leeper, an associate professor of surgery and cardiovascular medicine at Stanford. “That suggests that the genes and pathways that drive human height are also likely to be ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Varicose Veins Source Type: news

Cardiac Dimensions launches pivotal Carillon mitral repair device trial
Cardiac Dimensions said today it launched a pivotal trial of the Carillon mitral valve repair device it’s developing, and that it enrolled and randomized its first patient in the trial. The Kirkland, Wash.-based company’s percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral annulus by bending the coronary sinus. Late last year the FDA granted an investigational device exemption for a 400-patient pivotal trial of the Carillon device. The first patient in the trial was enrolled and ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Cardiac Dimensions Source Type: news

Cardiac Dimensions launches pivotal trial for Carillon mitral repair device
Cardiac Dimensions said today it launched a pivotal trial of the Carillon mitral valve repair device it’s developing, and that it enrolled and randomized its first patient in the trial. The Kirkland, Wash.-based company’s percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral annulus by bending the coronary sinus. Late last year the FDA granted an investigational device exemption for a 400-patient pivotal trial of the Carillon device. The first patient in the trial was enrolled and ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Cardiac Dimensions Source Type: news

Can LivaNova Succeed Where Others Have Failed in HF?
LivaNova continues to live up to the promise it made to shareholders that it would focus more on its neuromodulation and cardiac surgery businesses. Through the VITARIA neuromodulation technology, the London and Houston, TX-based firm is fulfilling that promise with one device and one fell swoop. “We clearly talk about ourselves as a company focused on the head and the heart,” Edward Andrle, LivaNova’s General Manager of Neuromodulation, told MD+DI. “What’s interesting about this therapy is that it is a neuromodulation therapy. But th...
Source: MDDI - September 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

FDA Approves First New Device for Heart Vessel Tears in 17 Years
  Cardiologists have a new tool for handling a rare but potentially life-threatening complication during percutaneous coronary intervention (PCI) procedures. FDA approved Biotronik's PK Papyrus Covered Coronary Stent System as a treatment for tears in the coronary arteries that can occur during heart vessel procedures. The PK Papyrus System is the first device FDA has approved for this indication in 17 years. The device has been CE marked for sale in Europe since 2013. "The PK Papyrus Covered Coronary Stent System provides healthcare providers with a new treatment option...
Source: MDDI - September 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news

CHF Solutions eyes post-cardiovascular surgery market
CHF Solutions (NSDQ:CHFS) said yesterday it plans to expand into the post-cardiovascular surgery market, specifically with products for patients who need treatment for fluid overload and have failed diuretic therapy. The Eden Prairie, Minn.-based company said that it sees the expansion into the post CV surgical market as a “natural next step” in its commercial expansion, as surgical patients often experience fluid overload challenges post procedure due to the administration of fluids during surgery. “The expansion of our sales and marketing team at CHF Solutions provides us the additional resources n...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Surgical CHF Solutions Inc. Source Type: news

3D virtual heart helps pinpoint irregular heartbeat
Researchers from Johns Hopkins University used a proprietary 3D virtual heart...Read more on AuntMinnie.comRelated Reading: VR, AR may revamp cardiovascular imaging Flexible 3D-printed heart replicates size, texture Funding, expertise give Jump an edge on 3D hearts 'Virtual heart' can guide who should get ICD implants 3D models put pediatric hearts in surgeons' hands (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2018 Category: Radiology Source Type: news

Dr. R. Taylor Ripley Leads Mesothelioma Center at Baylor
Thoracic surgeon Dr. R. Taylor Ripley comes to the Mesothelioma Treatment Center at Baylor College of Medicine with the highest possible endorsement. Dr. David Sugarbaker, the world’s most prominent mesothelioma specialist and director of the prestigious Baylor Lung Institute, recruited Ripley. It was like being anointed by the king. Ripley spent the previous four years at the National Cancer Institute (NCI) in Bethesda, Maryland, where he built a sterling reputation for surgical, clinical and investigational research excellence. “Dr. Sugarbaker wanted someone to help grow his program. He recruited me to do tha...
Source: Asbestos and Mesothelioma News - September 12, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Ripley Named New Director of Mesothelioma Center at Baylor
Thoracic surgeon Dr. R. Taylor Ripley comes to the Mesothelioma Treatment Center at Baylor College of Medicine with the highest possible endorsement. Dr. David Sugarbaker, the world’s most prominent mesothelioma specialist and former director of the prestigious Baylor Lung Institute, recruited Ripley. It was like being anointed by the king. Ripley spent the previous four years at the National Cancer Institute (NCI) in Bethesda, Maryland, where he built a sterling reputation for surgical, clinical and investigational research excellence. “Dr. Sugarbaker wanted someone to help grow his program. He recruited me to...
Source: Asbestos and Mesothelioma News - September 12, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Wearable ultrasound patch monitors blood pressure deep inside body
(University of California - San Diego) A new wearable ultrasound patch that non-invasively monitors blood pressure in arteries deep beneath the skin could help people detect cardiovascular problems earlier on and with greater precision. In tests, the patch performed as well as some clinical methods to measure blood pressure. Applications include real-time, continuous monitoring of blood pressure changes in patients with heart or lung disease, as well as patients who are critically ill or undergoing surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 12, 2018 Category: International Medicine & Public Health Source Type: news

Surgery for Mesothelioma No Longer Recommended in UK
Aggressive surgery for the treatment of malignant pleural mesothelioma (MPM) — unless part of a clinical trial — is no longer being recommended in the United Kingdom. The British Thoracic Society recently published its Mesothelioma Management Guidelines for 2018 and removed surgery from its recommendations. The belief was that potential harm was not worth the risk. The backtrack on surgery included the extrapleural pneumonectomy (EPP), the extended pleurectomy and decortication (P/D) and the partial pleurectomy (PP) — all of which are being done at cancer centers in the United States. “Surgery is a ...
Source: Asbestos and Mesothelioma News - September 11, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

9/11 Cancer Deaths Continue to Rise
John Feal believes more people will die from illnesses related to 9/11 than from the terrorist attack at the World Trade Center. He should know. He’s a first responder who witnesses it every day. And he is not alone in his belief. Feal, a longtime advocate for Sept. 11 survivors and those dying from diseases related to the terrorist attacks, will again host the annual naming ceremony at the 9/11 Responders Remembered Park in Smithtown, Long Island. Each year he reads the names of those who have died within the past year. And each year, the list is longer than the last. On the 17th anniversary of the terrorist attack...
Source: Asbestos and Mesothelioma News - September 10, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

iMedicalApps: This Week's Top Picks for iOS and Android
(MedPage Today) -- Surgery and nursing apps hit the mark (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 7, 2018 Category: Cardiology Source Type: news

A Better Analysis of Carotid Stenting vs Surgery?
(MedPage Today) -- Instrumental variable analysis moves the needle closer to parity in observational studies (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 7, 2018 Category: Cardiology Source Type: news

Gore Enhances Structural Heart Portfolio with Pipeline Deal
W. L. Gore & Associates is piping some money into a company that has been stealthily developing an entirely catheter-based repair procedure for patients with mitral valve disease. Flagstaff, AZ-based Gore has acquired Santa Rosa, CA-based Pipeline Medical Technologies for an undisclosed sum. Pipeline is developing a device designed to replicate the outcomes of a highly effective surgical procedure via a catheter, avoiding the trauma and many of the risks associated with open heart surgery. "Pipeline's cutting-edge repair procedure, for patients with mitral valve disease, has the potential to expand Gore's growing ...
Source: MDDI - September 6, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news

Gore picks up stealthy Pipeline Medical and its mitral repair program
W.L. Gore & Assoc. said today that it acquired stealthy Pipeline Medical Technologies and its mitral repair program for an undisclosed amount. Santa Rosa, Calif.-based Pipleline is developing a transcatheter device designed to duplicate the efficacy and outcomes found when mitral valve chords are repaired via open heart surgery. Gore said it plans to run the company as a wholly owned subsidiary under the Pipeline brand. “The addition of Pipeline’s investigational technology and talented associates bolsters our continued ambition to improve patients’ lives by offering physicians innovative treatme...
Source: Mass Device - September 6, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Mergers & Acquisitions Replacement Heart Valves Pipeline Medical Technologies W.L. Gore & Associates Source Type: news

Dr. David Sugarbaker, Mesothelioma Treatment Pioneer, Dies at 65
Thoracic surgeon Dr. David Sugarbaker, a world leader in advancing the treatment of pleural mesothelioma for nearly 30 years, has died. He was 65. Sugarbaker was director of the Lung Institute at the Baylor College of Medicine in Houston. Dr. Raja Flores, thoracic surgeon and mesothelioma specialist at Mount Sinai Cancer Center, expressed his respect for the famed surgeon. “He was a giant in the field. He not only took care of the mesothelioma patients, he trained a whole generation of doctors who will continue taking care of those patients,” said Flores, who trained under Sugarbaker. “It’s a sad...
Source: Asbestos and Mesothelioma News - August 29, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Gore tests stent graft for deadly heart condition
W.L. Gore’s ascending stent graft for Type A dissection of the ascending aorta W. L. Gore & Associates announced the first implant of its ascending stent graft, an investigational device and the only endovascular stent graft specifically designed to treat Type A dissections of the ascending aorta. The surgery was part of Gore’s ARISE study, the first multicenter, early feasibility study approved by the FDA to investigate how an endovascular stent graft, delivered via catheter, may be used to line the dissected portion of the ascending aorta as a less-invasive alternative to open surgical repair. Similar end...
Source: Mass Device - August 27, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Stent Grafts Surgical W.L. Gore & Associates Source Type: news

HeartFlow touts registry study, large hospital trial data
HeartFlow this week released data from two studies of its HeartFlow fractional flow reserve FFRct analysis system, touting that the system allows for the more effective differentiation of patients who need coronary stenting or bypass surgery and those who can be managed on medications alone. HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions. Results from the Advance registry study were published in the European Heart Journal and results from the Aarhus U...
Source: Mass Device - August 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials HeartFlow Source Type: news

I have had a heart attack. Do I need open heart surgery or a stent?
(European Society of Cardiology) New advice on the choice between open heart surgery and inserting a stent via a catheter after a heart attack is launched today. The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on myocardial revascularization are published online in European Heart Journal, and on the ESC website. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2018 Category: International Medicine & Public Health Source Type: news

VTE Risk May Hurt Survival After Kidney Cancer Surgery
(MedPage Today) -- Multiple factors seen worsening thromboembolism problem (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 18, 2018 Category: Cardiology Source Type: news

Radiofrequency Ablation Fixes Mesothelioma Recurrence in Case Study
Radiofrequency ablation (RFA) has been used successfully in Japan to treat post-surgery recurrence of malignant pleural mesothelioma, according to a case study published recently by the Society of Thoracic Surgeons. Although RFA has been utilized for several years to treat various thoracic lesions, the study authors believe this is the first time it worked effectively with mesothelioma cancer cells. “It shows promising efficacy,” the authors wrote. “Radiofrequency should be considered an option for treating recurrence of MPM [malignant pleural mesothelioma].” RFA is a minimally invasive medical proc...
Source: Asbestos and Mesothelioma News - August 15, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Improving Surgery for Mesothelioma with Glowing Tumor Technology
Thoracic surgeon Dr. Sunil Singhal at the Abramson Cancer Center has developed glowing tumor technology that should increase the effectiveness of aggressive surgery for malignant pleural mesothelioma. Singhal has shown recently that by adding a contrast agent that makes tumor cells glow, a more complete surgery can be done. This potentially avoids the now almost-inevitable cancer recurrence. “This is a big deal. We could potentially help a lot of patients with this,” Singhal told Asbestos.com. “It could change the entire field [of surgery for mesothelioma].” Singhal and his colleagues from the Abram...
Source: Asbestos and Mesothelioma News - August 9, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

In T2D, Bariatric Surgery Is Tops for Microvascular Risk Reduction (CME/CE)
(MedPage Today) -- Lowered risk for neuropathy, nephropathy, and retinopathy maintained for several years (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 6, 2018 Category: Cardiology Source Type: news

LivaNova touts completion of 1st-in-man transseptal Caisson TMVR feasibility study
LivaNova (NSDQ:LIVN) said today it concluded the Prelude first-in-human feasibility study exploring the transseptal use of its Caisson transcatheter mitral valve replacement system designed to treat mitral valve regurgitation. In the study, investigators explored the use of the Caisson TMVR system through a transseptal approach, which the London-based company claims is a less-invasive approach which uses a catheter inserted through an incision in the groin instead of an opening in the chest. LivaNova touted “positive patient outcomes” from the study, but has not released data from it. The company said that...
Source: Mass Device - August 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves LivaNova Source Type: news

JenaValve launches feasibility study of next-gen pericardial TAVR system
JenaValve Technology said today it launched an FDA investigational device exemption cleared early feasibility study of its next generation JenaValve pericardial transcatheter aortic valve replacement system. The newly launched trial will explore the use of the device as a minimally invasive treatment for patients with symptomatic, severe aortic stenosis and symptomatic aortic regurgitation in patients who are considered at extreme or high risk for open surgery. “Both myself and my CUMC colleagues, Dr. Susheel Kodali and Dr. Torsten Vahl, are extremely pleased to be the first U.S. physicians to treat patients wit...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves JenaValve Source Type: news

CarboFix wins FDA nod for its carbon/PEEK pedicle screws
CarboFix Orthopedics Ltd. has won FDA approval for a spinal screw system for use in people with advanced spinal cancer. The CarboClear carbon fiber pedicle screw system was designed to restore the integrity of the spinal column, even in the absence of fusion, for a limited time period in patients with advanced-stage thoracic and lumbar spine tumors. The screw system will hold the spine securely until patients are able to undergo spinal fusion, according to the Herzeliya, Israel-based company. The FDA gave the system 510(k) clearance. CarboClear pedicle screws are made of continuous carbon fibers reinforced polymer (PE...
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Implants Oncology Surgical CarboFix Orthopedics FDA icotec AG Source Type: news

CMS panel votes on volume requirements for TAVR centers
The Center for Medicare and Medicaid Services’ Medicare Evidence Development and Coverage Advisory Committee this week opened itself to comments and voted on volume requirements for new and existing transcatheter aortic valve replacement programs and operators. Panelists heard data from individuals across the healthcare spectrum, and ended up voting in the middle on most of the issues, according to a Medscape report. Voting was done on a one-to-five scale of confidence, with five showing high confidence in the resolution, according to the report. On considering hospitals with no TAVR experience opening new programs, ...
Source: Mass Device - July 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Regulatory/Compliance Replacement Heart Valves Centers for Medicare and Medicaid Services (CMS) Source Type: news

Abbott Makes Strong Statement in TMVR Space with SUMMIT
Abbott Laboratories has hit a substantial milestone in its plan to bring the Tendyne transcatheter mitral valve replacement (TMVR) system to the U.S. market. The Abbott Park, IL-based company said it has initiated SUMMIT, a pivotal clinical study of the TMVR system. Up to 1,010 patients will be enrolled in up to 80 sites in the pivotal trial. Abbott said the investigational Tendyne device is the first and only mitral valve replacement that can be repositioned and fully retrieved, allowing the surgeon to precisely place the device during implantation, which could improve patient outcomes. Tendyne is a tri-leaflet, bioprost...
Source: MDDI - July 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Cardiovascular Source Type: news

Specialized approach to open heart surgery saves lives
(Elsevier) Patients who undergo coronary artery bypass grafting (CABG) -- the most common heart surgery performed -- may live longer and experience fewer complications when under the care of a highly focused surgical team that uses simplified and standardized approaches, according to research published today in The Annals of Thoracic Surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2018 Category: International Medicine & Public Health Source Type: news

Meril Aims for Emerging Markets with its TAVR Device
Yet another company is throwing its hat into the transcatheter aortic valve replacement system (TAVR) market. However, Meril Lifesciences is going a different route than other established firms in the space and is initially targeting emerging markets. Meril has been around for 10 years and has been developing its MyVal TAVR technology for about six of those. The company’s success in TAVR lies around the fact that larger organizations don’t consider emerging markets as the first option. The company said it would seek out approval in India first and eventually make its way to developed markets. “We are posi...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

Mitral Valve Operations Now Fastest-Growing Heart Surgery (CME/CE)
(MedPage Today) -- Earlier referral, though, needed to optimize outcomes (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 19, 2018 Category: Cardiology Source Type: news

Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - July 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news